Where does OliX Pharmaceuticals. Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), OliX Pharmaceuticals. Inc. ranks #18,974 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does OliX Pharmaceuticals. Inc. hold?

OliX Pharmaceuticals. Inc. holds 15 US utility patents granted between 2018 and 2023, spanning 7 technology areas.

What is OliX Pharmaceuticals. Inc.'s Innovation Score?

OliX Pharmaceuticals. Inc. has an Innovation Score of 29.7 out of 100 (31st percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is OliX Pharmaceuticals. Inc.'s patent grant rate increasing or decreasing?

OliX Pharmaceuticals. Inc.'s recent grant velocity is +14% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for OliX Pharmaceuticals. Inc.'s patents?

OliX Pharmaceuticals. Inc.'s patents average 16.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the OliX Pharmaceuticals. Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

OliX Pharmaceuticals. Inc.

Q: What technology areas does OliX Pharmaceuticals. Inc. focus on?

OliX Pharmaceuticals. Inc.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 15 patents, ranking #709 of 4,144 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 15 granted patents across 7 technology areas, recorded in grant years 2018–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Olix ranks #18,974 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 7 technology areas.

#18,974
of 49,997 US assignees by volume: 31st percentile
by Innovation Score (29.7/100): 16.9
avg claims per patent: +14%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18974 · Foreign Corporation #18,974 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-UP · BOOK-FULL

GRANTS-MICRO 15 grants
MID-PACK #18,974/49,997
PHOTO-FINISH Oasis Medical
CPC-NARROW C12N · 7 areas
INNOV-THIN 29.7/100
CLAIMS-RICH 16.9 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-UP +14% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Oasis Medical, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Olix’s 29.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.6 pts (32%) Velocity 0.6 pts (2%) Breadth 9.4 pts (32%) Claim depth 10.1 pts (34%)

Qualcomm Incorporated · highest

85
OliX Pharmaceuticals · this assignee

30
3D Lighting… · lowest

7

What this shows Olix's Innovation Score is 29.7/100 (31st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Olix?

Each dot is one of Olix’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Olix’s own 16.9 claims/patent is ABOVE the 14.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Olix vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Olix's grants concentrate

OliX Pharmaceuticals. Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2019 (4 grants) versus a trough of 1 in 2023. By volume, Olix sits between Oasis Medical, Inc. and OneSpan North America Inc..

Olix's three-year grant acceleration

OliX Pharmaceuticals. Inc. shows 1 grants in 2022–2024 against only 11 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Oasis Medical

15
Oasyschair

15
Obeebo Labs

15
Odfjell Well Serv…

15
Omnivision Sensor…

15
On Target Laborat…

15
On-chip Biotechno…

15
Onespan North Ame…

15
Olix Pharmaceutic… ◀

15

What this shows OliX holds 15 patents at rank #18,976, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near OliX

By rank, the assignees closest to #18,976 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in OliX's primary technology class.

Olix's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 31st percentile higher than 31% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2018–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table

OliX Pharmaceuticals. Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2018	3	20.0%
2019	4	26.7%
2020	3	20.0%
2021	4	26.7%
2023	1	6.7%

Which technologies does OliX Pharmaceuticals. Inc. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 15

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 14

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

C12Y - Enzymes 3

A61Q - Specific USE OF Cosmetics OR Similar Toiletry Preparations 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

C07K - Peptides 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

OliX Pharmaceuticals. Inc.'s patent record in context - here's where to go next.

OliX Pharmaceuticals. Inc.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #18,974 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare OliX Pharmaceuticals. Inc. against Oasis Medical, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.